Rubbert-Roth A - Search Results

1

German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Albrecht K, Krüger K, Wollenhaupt J, Alten R, Backhaus M, Baerwald C, Bolten W, Braun J, Burkhardt H, Burmester GR, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Kuipers J, Krause A, Lorenz HM, Manger B, Nüßlein H, Pott HG, Rubbert-Roth A, Schneider M, Specker C, Schulze-Koops H, Tony HP, Wassenberg S, Müller-Ladner U; German Society of Rheumatology. Albrecht K, et al. Rheumatol Int. 2014 Jan;34(1):1-9. doi: 10.1007/s00296-013-2848-3. Epub 2013 Aug 14. Rheumatol Int. 2014. PMID: 23942828 Review.

2

Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA.

Schmiedeberg K, Abela IA, Pikor NB, Vuilleumier N, Schwarzmueller M, Epp S, Pagano S, Grabherr S, Patterson AB, Nussberger M, Trkola A, Ludewig B, von Kempis J, Rubbert-Roth A. Schmiedeberg K, et al. RMD Open. 2022 Oct;8(2):e002575. doi: 10.1136/rmdopen-2022-002575. RMD Open. 2022. PMID: 36288822 Free PMC article.

3

Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases.

Finckh A, Ciurea A, Raptis CE, Rubbert-Roth A. Finckh A, et al. J Infect Dis. 2023 Aug 4;228(Suppl 1):S13-S23. doi: 10.1093/infdis/jiad148. J Infect Dis. 2023. PMID: 37539758 Free PMC article.

4

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.

Blockmans D, Penn SK, Setty AR, Schmidt WA, Rubbert-Roth A, Hauge EM, Keen HI, Ishii T, Khalidi N, Dejaco C, Cid MC, Hellmich B, Liu M, Zhao W, Lagunes I, Romero AB, Wung PK, Merkel PA; SELECT-GCA Study Group. Blockmans D, et al. Among authors: rubbert roth a. N Engl J Med. 2025 May 29;392(20):2013-2024. doi: 10.1056/NEJMoa2413449. Epub 2025 Apr 2. N Engl J Med. 2025. PMID: 40174237 Clinical Trial.

5

Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry.

Ciurea A, Götschi A, Bräm R, Bürki K, Exer P, Andor M, Nissen MJ, Möller B, Hügle T, Rubbert-Roth A, Kyburz D, Distler O, Scherer A, Micheroli R. Ciurea A, et al. RMD Open. 2023 Dec 1;9(4):e003455. doi: 10.1136/rmdopen-2023-003455. RMD Open. 2023. PMID: 38053462 Free PMC article.

6

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, Woodworth T, Alten R; OPTION Investigators. Smolen JS, et al. Lancet. 2008 Mar 22;371(9617):987-97. doi: 10.1016/S0140-6736(08)60453-5. Lancet. 2008. PMID: 18358926 Clinical Trial.

7

[Recommendations on the use of rituximab for patients with rheumatoid arthritis].

Rubbert-Roth A, Burmester G; Kommission Pharmakotherapie der DGRh. Rubbert-Roth A, et al. Z Rheumatol. 2008 Nov;67(7):609-13. doi: 10.1007/s00393-008-0348-8. Z Rheumatol. 2008. PMID: 18830700 German. No abstract available.

8

Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR).

Rubbert-Roth A, Tak PP, Zerbini C, Tremblay JL, Carreño L, Armstrong G, Collinson N, Shaw TM; MIRROR Trial Investigators. Rubbert-Roth A, et al. Rheumatology (Oxford). 2010 Sep;49(9):1683-93. doi: 10.1093/rheumatology/keq116. Epub 2010 May 12. Rheumatology (Oxford). 2010. PMID: 20463186 Free PMC article. Clinical Trial.

9

[Recommendations of the German rheumatology society on the use of tocilizumab in rheumatoid arthritis].

Gause A, Rubbert-Roth A, Michels H, Gaubitz M, Mayet WJ; Kommission Pharmakotherapie der DGRh. Gause A, et al. Z Rheumatol. 2010 Jun;69(4):365-72. doi: 10.1007/s00393-010-0612-6. Z Rheumatol. 2010. PMID: 20495924 German.

10

Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA).

Burmester GR, Feist E, Kellner H, Braun J, Iking-Konert C, Rubbert-Roth A. Burmester GR, et al. Ann Rheum Dis. 2011 May;70(5):755-9. doi: 10.1136/ard.2010.139725. Epub 2010 Dec 27. Ann Rheum Dis. 2011. PMID: 21187298 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters